Note: Ingredients listed on restricted chemical lists
EC/CAS
12227-78-0
Name of the chemical
2′,4′,5′,7′-Tetraiodofluorescein, its disodium salt (Acid Red 51; CI 45430) and its aluminium salt (Pigment Red 172 Aluminium lake) when used as a substance in hair dye products
Concentration
N/A
EC/CAS
235-440-4
Name of the chemical
2′,4′,5′,7′-Tetraiodofluorescein, its disodium salt (Acid Red 51; CI 45430) and its aluminium salt (Pigment Red 172 Aluminium lake) when used as a substance in hair dye products
Concentration
N/A
General Information
Revision date
2022-03-09
Product name
CALMEPAM TABLETS
Product Synonyms
CALMEPAM TABLETS 1.5 MG * CALMEPAM TABLETS 3 MG * BROMAZEPAM, FORMULATED
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Serious eye damage/eye irritation Category 2 H319 - Causes serious eye irritation. Hazard summary Caution - Pharmaceutical agent. Causes serious eye irritation. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Signal word
Warning
Hazard statements
H319 Causes serious eye irritation.
Prevention
P264 Wash thoroughly after handling. P280 Wear eye protection/face protection.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/attention.
Storage
Not available.
Disposal
P501 Dispose of contents/container (in accordance with related regulations).
Supplemental label elements
51.15 % of the mixture consists of component(s) of unknown acute oral toxicity. 98.25 % of the mixture consists of component(s) of unknown acute dermal toxicity. 97.05 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 98.25 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
